Uriten<sup>®</sup>
Uriten®
Alfuzosin HCl
BPH Products (Drugs for Urinary Incontinence)
Indication: Uriten is used for the treatment of functional symptoms of Benign Prostatic Hyperplasia (BPH). It is also used as a short term treatment of acute urinary retention (AUR) related to BPH patients (over 65 years) in association with catheterization.

Dosage & Administration: BPH: 10 mg once daily immediately after the same meal each day. AUR: 10 mg once daily immediately after the same meal each day. Dose should be started from the first day of catheterization. The treatment should be continued for 3-4 days (2-3 days during catheterization and 1 day after its removal). The tablet should be swallowed whole. The tablets should not be chewed or crushed. These actions may lead to an inappropriate release and absorption of the drug and therefore possible early adverse reaction.

Preparation: Uriten® ER Tablet: Box containing 30 tablets.
Other Products From Drugs for Urinary Incontinence
Maxrin<sup>®</sup>
Maxrin®

Tamsulosin HCl

BPH Products

Pronor<sup>®</sup>
Pronor®

Finsteride

BPH Products

Uriten<sup>®</sup>
Uriten®

Alfuzosin HCl

BPH Products

Ucol<sup>TM</sup>
UcolTM

Tolterodine Tartrate

Urge Incontinence

fancybox/jquery.mousewheel-3.0.4.pack.js">